Molecular mechanisms of actions, pharmacokinetics and anti-inflammatory potency of inhaled glucocorticosteroids (ICS) are described. Differences in clinical effectiveness of ICS in asthma and chronic obstructive pulmonary disease (COPD) therapy and up-to-date recommendations for treatment with ICS in asthma and COPD patients are discussed. Finally there are presented data on safety of long-term treatment with ICS, specially in asthmatic children.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
asthma chronic
8
chronic obstructive
8
obstructive pulmonary
8
ics asthma
8
treatment ics
8
[inhaled glucocorticosteroids
4
glucocorticosteroids treatment
4
treatment asthma
4
pulmonary disease]
4
disease] molecular
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!